Evidence map›Paper›PMID 39939862›Full record

ReviewDiabetology & metabolic syndrome2025

Screening and management of hospital hyperglycemia in non-critical patients: a position statement from the Brazilian Diabetes Society (SBD).

Emerson Cestari Marino, Denise Momesso, Marcos Tadashi Kakitani Toyoshima, Maria Fernanda Ozorio de Almeida, Beatriz D Schaan, Leandra Anália Freitas Negretto, Augusto Cezar Santomauro Junior, Priscilla Cukier, Paulo Roberto Rizzo Genestreti, Alina Coutinho Rodrigues Feitosa and 5 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Diabetology & metabolic syndrome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Emerson Cestari MarinoCuritiba Diabetes Center, Curitiba, Brazil. dremersonmarino@gmail.com.
Denise MomessoEndocrinology Service, Universidade Federal Do Estado Do Rio de Janeiro, Rio de Janeiro, Brazil.
Marcos Tadashi Kakitani ToyoshimaEndocrine Oncology Unit, Instituto Do Câncer Do Estado de São Paulo Octavio Frias de Oliveira, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Maria Fernanda Ozorio de AlmeidaCuritiba Diabetes Center, Curitiba, Brazil.
Beatriz D SchaanFaculdade de Medicina da Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.
Leandra Anália Freitas NegrettoHospital Israelita Albert Einstein, Goiânia, Brazil.
Augusto Cezar Santomauro JuniorEndocrinology and Metabolism Service, Hospital BP-Beneficência Portuguesa of São Paulo, São Paulo, Brazil.
Priscilla CukierHospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Paulo Roberto Rizzo GenestretiInstituto Do Coração, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.
Alina Coutinho Rodrigues FeitosaEndocrinology Service, Hospital Santa Izabel da Santa Casa da Bahia, Salvador, Brazil.
Jorge Eduardo da Silva Soares PintoInternal Medicine Department, State University of Rio de Janeiro, Rio de Janeiro, Brazil.
Rogerio Silicani RibeiroHospital Israelita Albert Einstein, São Paulo, Brazil.
Rodrigo Nunes LamounierInternal Medicine Department, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Ruy LyraEndocrinology and Metabolism Service, Federal University of Pernambuco, Recife, Brazil.
Marcello Casaccia BertoluciFaculdade de Medicina da Universidade Federal Do Rio Grande Do Sul, Porto Alegre, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHospital Hyperglycemia (HH) is linked to poorer outcomes, including higher mortality rates, increased ICU admissions, and extended hospital stays, and occurs in both people living with diabetes or not. The prevalence of HH in non-critical patients ranges from 22 to 46%. This panel reviewed the evidence and made recommendations for the best care for hospitalized hyperglycemic patients, with or without diabetes mellitus.

methodsThe methodology was published previously and was defined by the internal institutional steering committee. The SBD Acute and Hospital Complications Department drafted the manuscript, selecting key clinical questions for a narrative review using MEDLINE via PubMed. The best available evidence was reviewed, including randomized clinical trials (RCTs), meta-analyses, and high-quality observational studies related to Hospital Hyperglycemia. RESULTS AND

conclusionsThe department members and external experts developed 23 recommendations for the management of patients with HH, including screening, initial interventions, treatment adjustments, and care for potential complications. Based on the best available evidence, our article provides safe and effective management strategies for both public and private healthcare settings.

Identifiers

PMID39939862
PMCPMC11823188

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.